Antibiotic Developments
WHO Report Shows Increase in HIV Drug Resistance to Dolutegravir
The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges. Read more
8 Mar 2024
SIRIO Launches New Consumer Health Gummies at CPHI Barcelona
Sirio Pharma will further expand its offering in the consumer health market, building on last month’s ‘pharma targeted’ softgel launch, with the introduction of a range of herbal gummies for trending consumer health categories. Read more
6 Oct 2023
ANL and SoundCell awarded grant for antibiotic sensitivity test
Applied Nanolayers BV (ANL) and SoundCell BV have received €275,000 R&D funding from Provincie Zuid-Holland to develop a prototype for SoundCell’s high throughput single-cell graphene antibiotic sensitivity test. Read more
27 Mar 2023
Accelerate Diagnostics announces CE marking of its antimicrobial kit
Accelerate Diagnostics, an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, announces CE marking of its new Accelerate Arc Module and BC kit. Read more
8 Aug 2022
Quidel Corp provides rapid clinical detection of C. difficile infection
The Sofia 2 C. difficile FIA (Fluorescent Immunoassay), from healthcare manufacturer Quidel Corporation, provides accurate detection of C. difficile in 15 minutes – half the time of comparator assays – allowing rapid treatment decisions. Read more
1 Jul 2022
Novasep and Paratek increase API manufacture for antibiotic
Technology supplier Novasep and Paratek Pharmaceuticals have signed an agreement to increase the commercial production of an active pharmaceutical ingredient (API) for an antibiotic. Read more
21 Feb 2022
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process. Read more
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Aramex Scoop Sustainability Award
Aramex has been awarded the Sustainability in Distribution award at the recent Distributing Pharmaceuticals UK award event at the Coventry Building Society Arena. Read more
26 Apr 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Berry Global Invests to Increase Production Capacity
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites. Read more
26 Apr 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Regeneron and Mammoth Biosciences to Collaborate
Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration to research, develop and commercialise in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. Read more
26 Apr 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Novartis Radioligand Therapy Lutathera FDA Approved
Novartis have announced that the FDA have approved Lutathera for the treatment of pediatric patients 12 years and older with somatostatin receptor-positive (SSTR+) gastroenteropancreatic neuroendocrine tumours. Read more
25 Apr 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Owlstone Medical Secures $6.5 Million to Support Development
Owlstone Medical have announced it has secured funding from the Bill & Melinda Gates Foundation. Read more
25 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
MHRA Approves YORVIPATH
Ascendis Pharma have announced that the United Kingdom’s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for YORVIPATH. Read more
25 Apr 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25